Elsevier

Brain Research Reviews

Volume 37, Issues 1–3, November 2001, Pages 141-152
Brain Research Reviews

Review
Estradiol, in the CNS, targets several physiologically relevant membrane-associated proteins

https://doi.org/10.1016/S0165-0173(01)00114-XGet rights and content

Abstract

We will describe the identity and function of two unexpected estrogen binding proteins from rat brain cell membranes in search for the putative membrane estrogen receptor (mER). An E-6-BSA column retained a distinctive 37-kDa protein that showed 100% homology with glyceraldehyde-3-phosphate dehydrogenase (GAPDH). A P-3-BSA column also retained the same protein but with less affinity. E-6-BSA bound to GAPDH with an IC50 of 50 nM, whereas the IC50 for P-3-BSA was about 500 nM. A dose of 10 nM 17β-estradiol stimulated the catalysis of GAPDH, whereas progesterone at 100 nM inhibited it. Other steroids were ineffective. We examined if GAPDH activity would change during the rat estrous cycle, and what would be the effect of ovariectomy and estrogen treatment. The hippocampus and cerebellum were collected and GAPDH catalysis in both cytosolic and plasmalemmal-microsomal fractions was tested. The highest activity was found in Proestrus morning and the lowest in Estrus in both fractions. After ovariectomy (3 weeks) the hippocampus membrane fraction showed significantly reduced activity compared to that of Diestrus. An injection of estradiol in ovariectomized rats (10 μg/rat, s.c.) increased GAPDH activity in the hippocampus membrane fractions close to 60% from that of ovariectomized oil-treated controls 24 h after treatment maintaining similar levels by 48 h. No changes were detected in the preparations from the cerebellum of the same rats. The other protein retained by E-BSA columns was a 55-kDa protein identified as β-tubulin. Two other proteins were also co-purified from the rat hippocampus: a 37-kDa (GAPDH) and a 45-kDa (actin). A purified brain tubulin (Cytoskeleton) was also retained with high affinity by the E-6-BSA, but with less affinity by an E-17-BSA column and not retained by either BSA, P-3-BSA or C-21-BSA columns. E-6-[125I]BSA bound with high affinity to tubulin (1 μg) and 17β-estradiol completely displaced the binding at 10−7 M. 17α-Estradiol was ineffective and neither progesterone, corticosterone, DES nor 2-methoxyestradiol (2-ME) was able to displace the ligand. The T-3-[125I]BSA also bound to tubulin. But it seems to interact with another binding site, because colchicine at 10−5 M completely eliminated the binding of T-3-[125 I]BSA to tubulin but did not displace the E-6-BSA site. Taxol competed off both ligands but only by 50%. None of the two ligands bound actin. These novel findings add new information to be considered in the intracellular actions of estradiol, particularly in the remodeling and functions of the cytoskeleton.

Introduction

In the last 5 years a remarkable increase in new findings pointed beyond reasonable doubt that estrogens in addition to the classical genomic pathway use membrane-initiated events to activate cellular mechanisms. For example, it is quite evident that estrogens activate the MAPK (mitogen-activated protein kinase) pathway in the CNS [45], [50], [51] as well in other tissues, such as MCF-7 breast cancer cells [21], [25], [37], human bone cells [4], [8] and endothelial cells [46], [49] to mention some; however, the initial event is still unclear. Also in other cells estrogen uses another signal transduction: the activation of Ca [29] and K [57] channels. We do not know how the steroid lead to changes in the activity of these channels: it could be either directly through specific binding sites in these proteins [57] or indirectly, through changes in cAMP [7], [29]. Though the activation of the G protein-coupled signal transduction pathway was established many years ago by the pioneer work of Szego et al. [52] a renew effort in this direction indicate that estradiol at physiological concentrations indeed used this non-genomic pathway to initiate a cascade of intracellular responses. For instance, 1 nM 17β-estradiol within 5 min stimulated the phosphorylation of Erk-1 and -2 proteins in both MCF-7 cells (with ER α(+) and ER β(+) receptors) and in SKBR3 cells which lack these receptors indicating that activation of this pathway does not require the nuclear estrogen receptors (nERs). In addition, the authors of this paper [9] clearly showed that estrogen-induced activation of the Erk proteins requires cellular expression of the G protein receptor homologue, GPR30, an orphan receptor. Curiously, under the conditions of their study ICI 182,780, considered a pure anti-estrogen, was also capable to activate the SKBR3 cells. The complexity of this pathway was also apparent from their results because the GPR30-mediated phosphorylation of the Erk proteins requires EGF receptor tyrosine kinase activity and occurs through the release of surface-associated heparin-binding EGF (epidermal growth factor). These results indicate that neither of the two nuclear receptors mediates the estrogen activation of the MAPK pathway; however, others have evidence indicating the need or presence of such receptors [42], [49], [59]. Future studies will be required to clarify such contradictory data. On the other hand, earlier work indicated that GPCRs (G protein-coupled receptors) stimulated by physiological doses of estrogen led to phospholipase C activation and that it is the G β, γ subunits rather than G α, the ones involved in the effect of 17β-estradiol in osteoblast cells [19].

The demonstration of specific and high affinity binding sites in the CNS for estradiol (for review see Ref. [40]) indicates that specific proteins mediate the so-called non-genomic actions of estradiol. Though several laboratories [5], [16], [56] including us [39] have reported proteins with affinity to estradiol, in some cases different in molecular size to the nERs, none of those proteins have been isolated and identified, except for OSCP, a subunit of the ATPase/ATP synthase [63], a novel target of estrogens. Another very interesting protein is c-erB2 because it binds with high affinity to estradiol [22], and some of the actions of this steroid may be mediated by this family of receptors [34], [35].

In this report we will review the current status of our efforts to isolate the so far elusive mER. The data clearly indicate that estradiol binds to several proteins in the CNS of which two have been isolated and characterized: GAPDH (glyceraldehyde-3-phosphate dehydrogenase) and β-tubulin. The former, a classical glycolytic enzyme but with new functions during the past 20 years [2], [12], [47]. The latter, a 55K protein essential for the formation of microtubules through a dynamic process of polymerization and depolymerization [48]. The overall review points to the concept that the elusive mER is not a single cognate protein but a myriad of membrane proteins with different but crucial functions at the cellular level.

Section snippets

The estradiol-binding proteins

Our laboratory has a long-term interest in the rapid action of estradiol and progesterone. Several papers indicate that both steroids can rapidly activate cellular processes leading to release of dopamine from rat striatal fragments superfused in vitro in the case of estradiol [1] and the E-6-BSA conjugate [39], and LHRH [41] in the case of progesterone. This latter steroid also modulates amphetamine-induced dopamine release [6] and the complex, P-3-BSA stimulated LHRH release from hypothalamic

Overview

Our efforts to isolate and identify a membrane estrogen receptor (mER) from the rat brain [38] and the liver [26] so far have failed. However, in the process of such studies we have identified several physiologically relevant estrogen binding proteins: OSCP [63], GAPDH [17], tubulin [20] and an isoform of CEH [27], all of them showing high affinity for 17β-estradiol. In this review, we will discuss the significance of the binding of estradiol to GAPDH and tubulin, the trust of the present

Conclusions and speculations

It appears from the information so far accumulated that steroids hormones activate specific brain cells by means of rapid membrane initiated events as well as by slower genomic mechanisms. The rapid initiated events by steroids involve a series of different target proteins among which GAPDH and tubulin have been identified. They should be considered in explaining some of the known effect of the sex hormones, particularly in cell morphology in general, and changes in dendritic density in the

Acknowledgements

The authors wish to thank Ms. Norma Ramirez for her technical help with the binding assays and Ms. Penny Morman for preparing the manuscript. This work was in part funded by a NIH Grant to Dr. V.D. Ramirez.

References (64)

  • P.W. Shaul

    Rapid activation of endothelial nitric oxide synthase by estrogen

    Steroids

    (1999)
  • A.C. Towle et al.

    Steroid binding to synaptic plasma membrane: differential binding of glucocorticoids and gonadal steroids

    J. Steroid Biochem.

    (1983)
  • N. Wang et al.

    Tubulin binds specifically to the Signal-transducing Proteins, Gsα and Giα1

    J. Biol. Chem.

    (1990)
  • J. Zheng et al.

    Purification an identification of an estrogen binding protein from rat brain: oligomycin sensitivity-conferring protein (OSCP), a subunit of mitochondrial F0F1-ATP synthase/ATPase

    J. Steroid Biochem. Mol. Biol.

    (1999)
  • J.B. Becker

    Direct effect of 17β-estradiol on striatum: sex differences in DA release

    Synapse

    (1990)
  • M.D. Berry et al.

    Glyceraldehyde-3-phosphate dehydrogenase and apoptosis

    J. Neurosci. Res.

    (2000)
  • M.M. Bradford

    A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

    Anal. Biochem.

    (1976)
  • K.D. Brubaker et al.

    Estrogen stimulates protein tyrosine phosphorylation and src kinase activity in avian osteoclasts

    J. Cell. Biochem.

    (1999)
  • C.M. Doolan et al.

    Rapid non-genomic activation of cytosolic cyclic AMP-dependent kinase activity and [Ca(2+)](i) by 17 β-estradiol in female rat distal colon

    Br. J. Pharmacol.

    (2000)
  • E.J. Filardo et al.

    Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homologue, GPR30, and occurs via transactivation of the epidermal growth factor receptor through the release of HB-EFG

    Mol. Endocrinol.

    (2000)
  • A. Ferreira et al.

    Estrogen-enhanced neurite growth: evidence for a selective induction of tau and stable microtubules

    J. Neurosci.

    (1991)
  • P.E. Glaser et al.

    Rapid plasmenylethanolamine-selective fusion of membrane bilayers catalyzed by an isoform of glyceraldehyde-3-phosphate dehydrogenase: discrimination between glycolytic and fusogenic roles of individual isoforms

    Biochemistry

    (1995)
  • E. Gould et al.

    Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood

    J. Neurosci.

    (1990)
  • E. Hamel et al.

    Interactions of 2-methoxyestradiol, an endogenous mammalian metabolite, with unpolymerized tubulin and with tubulin polymers

    Biochemistry

    (1996)
  • X. Han et al.

    Reconstitution of membrane fusion between pancreatic islet secretory granules and plasma membranes: catalysis by a protein constituent recognized by monoclonal antibodies directed against glyceraldehyde-3-phosphate dehydrogenase

    Biochim. Biophys. Acta

    (1998)
  • A. Horvat et al.

    Estradiol binding to synaptosomal plasma membrane of rat brain regions

    Experientia

    (1995)
  • F.C. Ke et al.

    Membrane mechanism mediates progesterone stimulatory effect on LHRH release from superfused rat hypothalami in vitro

    Neuroendocrinology

    (1987)
  • V. Le Mellay et al.

    Gαq/11 and Gβγ proteins and membrane signaling of calcitriol and estradiol

    J. Cell. Biochem.

    (1999)
  • J. Liu et al.

    Isolation and characterization of tubulin from the rat hippocampus using an estradiol-BSA affinity column: demonstration of specific binding sites to estradiol (E) and testosterone (T)

    Soc. Neurosci. Abstr.

    (2000)
  • E.K. Lobenhofer et al.

    Inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase activity in MCF-7 cells prevents estrogen-induced mitogenesis

    Cell Growth Differ.

    (2000)
  • S. Matsuda et al.

    17β-Estradiol mimics ligand activity of the c-erB2 protooncogene product

    Proc. Natl. Acad. Sci. USA

    (1993)
  • B.S. McEwen

    Gonadal hormone regulation of synaptic plasticity in the brain

  • Cited by (0)

    View full text